CKD Bio Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 0.0004 million compared to negative sales of KRW 0.00059 million a year ago.

Net loss was KRW 6,576.6 million compared to net income of KRW 6,207.4 million a year ago. Basic loss per share from continuing operations was KRW 1,199 compared to basic earnings per share from continuing operations of KRW 1,147 a year ago. Basic loss per share was KRW 1,199 compared to basic earnings per share of KRW 1,147 a year ago.